2-5A(pppA2'p5'A2'p5'A) in interferon-treated encephalomyocarditis virus-infected mouse L-cells.
D000227:Adenine Nucleotides / Q000032:analysis / Q000378:metabolism* / Q000494:pharmacology; D000818:Animals; D004686:Encephalomyocarditis virus; D004769:Enterovirus Infections / Q000378:metabolism*; D007372:Interferons / Q000494:pharmacology*; D007739:L Cells / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D009841:Oligonucleotides / Q000378:metabolism*; D009843:Oligoribonucleotides / Q000032:analysis / Q000378:metabolism* / Q000494:pharmacology; D012335:RNA, Ribosomal / Q000378:metabolism; D012367:RNA, Viral / Q000378:metabolism
D000227:Adenine Nucleotides; D009841:Oligonucleotides; D009843:Oligoribonucleotides; D012335:RNA, Ribosomal; D012367:RNA, Viral; C023505:2',5'-oligoadenylate; D007372:Interferons